AzTrials
AzTrials

Class II Division 1 MalocclusionNCT00957489

A Prospective Randomized Controlled Trial to Evaluate the Effectiveness of the Two Different Appliances in the Treatment of Class II Division 1 Malocclusion

A study testing Dynamax appliance and Twin-block appliance in people with Class II Division 1 Malocclusion, run by University of Manchester at 2 sites in United Kingdom.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Twin-Block treatment and Dynamax treatment for Class II division 1 malocclusion do not have different effects with regards to treatment duration, the quality of dento-occlusal outcome, skeletal and soft tissue profile, patient discomfort and gingival health. Read more about this study

Who is it for?
Ages 10 to 14 yearsHealthy volunteers can take part
Conditions the study is for
Class II Division 1 Malocclusion
What is being tested?
Dynamax appliance and Twin-block appliance
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
2 sitesUnited Kingdom
Study dates
Jan 2007to Sep 2008
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 14 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Patients with a Class II malocclusion as defined by British Standards Institute classification.
  • Overjet greater than 6mm
  • Aged 10-14 years
  • Clinical examination indicates a functional appliance is not contraindicated

Who cannot join

  • Orthognathic treatment is required or there is a strong indication it will be required in the future
  • Possession of a craniofacial anomaly
  • Previous orthodontic treatment and/or premolar extraction
  • Hypodontia of more than one teeth in any quadrant excluding third molars
  • Inadequate oral hygiene

Trial locations and contacts

2 sites in 1 country.

United Kingdom2 sites
  • Chesterfield Royal Hospital

    Chesterfield

  • Derby Royak Hospital NHS Trust

    Derby

Other trials in United Kingdom

About this study

Twin-Block treatment and Dynamax treatment for Class II division 1 malocclusion do not have different effects with regards to treatment duration, the quality of dento-occlusal outcome, skeletal and soft tissue profile, patient discomfort and gingival health.

Read the detailed description

The Dynamax appliance is a relatively new appliance for the treatment of Class II malocclusion and was introduced in 2003. The appliance has the theoretical advantages of incremental mandibular advancement without the need for bite registration, and the ability for the operator to simultaneously provide the functional and fixed appliance phases of treatment. Furthermore, the Dynamax appliance is designed to limit lower both lower incisor proclination and upper incisor retroclination without an increase in lower facial height. There has been limited research into this appliance and only one trial has been carried out. In this study the effects of the Dynamax were compared with the Twin-block, unfortunately, the trial was not carried out to contemporary standards and suffered from severe shortcomings. For example, the non compliance rate was not accounted for in the sample size calculation, the randomisation sequence was not clear, the investigators did not carry out an intention-to-treat analysis, the statistical analysis was simplistic and the study was carried out in a single dental school setting. This raises the question about the efficiency of the Dynamax appliance and whether or not they are effective in a 'real' world setting.

The aim of this study is to compare the effectiveness of the Dynamax appliance and the Twin-block appliance for the treatment of Class II Division 1 malocclusion.

Being tested
Dynamax appliance, Twin-block appliance
Keywords
Orthodontic treatment of Class II division 1 malocclusion
Medical subject headings
Malocclusion, Angle Class II

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dynamax applianceOther

  • Twin-block applianceOther

Study groups in NCT00957489
Study groupRoleWhat they receive
Functional appliance-DynamaxExperimentalNot described
Receives: Other: Dynamax appliance
Functional appliance- twin blockOtherConventional treatment
Receives: Other: Twin-block appliance

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Duration of treatment with functional appliance

    Measured: 9 months

  2. Overjet measurement

    Measured: 9 months

Secondary outcomes (1)
  1. Harms Breakages Number of treatment visits Total treatment time Quality of occlusal result (PAR Index) Restricted cephalometric (radiograph) analysis Patient perception questionnaire at six months into treatment

    Measured: 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Aug 2009 (estimated)
  2. Study startJan 2007
  3. Primary completionSep 2008
  4. Study completionSep 2008

Why it stopped: Study stopped due to increased harm and slow progress in the intervention group.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
64 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00957489
Sponsor's protocol ID
DTT project
Status last verified
May 2023
First submitted
11 Aug 2009
Last updated
16 May 2023
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Dynamax appliance and Twin-block appliance in people with Class II Division 1 Malocclusion, run by University of Manchester at 2 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 16 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Study stopped due to increased harm and slow progress in the intervention group.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Duration of treatment with functional appliance (time frame: 9 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in